
BBWI
USDBath & Body Works Inc.
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$30.750
High
$31.370
Low
$30.560
Volume
0.54M
Company Fundamentals
Market Cap
6.7B
Industry
Specialty Retail
Country
United States
Trading Stats
Avg Volume
5.84M
Exchange
NYQ
Currency
USD
52-Week Range
AI Analysis Report
Last updated: Apr 28, 2025BBWI: Bath & Body Works Inc. - Checking the Pulse on Recent Activity
Stock Symbol: BBWI Generate Date: 2025-04-28 14:04:56
Let's break down what's been happening with Bath & Body Works stock lately, looking at the news, how the price has moved, and what some predictions are saying.
Recent News Buzz: A Mixed Bag?
The news flow around BBWI recently has been interesting, showing a bit of a split view from the pros. Several big-name analysts – folks from Goldman Sachs, Raymond James, JP Morgan, Citigroup, and Piper Sandler – have weighed in. The good part? They're mostly keeping their positive ratings on the stock, like "Buy," "Outperform," or "Overweight." This suggests they still see value in the company itself.
But here's the catch: almost all of them lowered their price targets. Think of a price target as where an analyst thinks the stock could trade in the future. So, while they still like the company, they seem a bit less optimistic about how high the stock might go in the near term compared to their previous views.
We also saw a general note about consumers looking for discounts because of things like tariff pressures. For a specialty retailer like Bath & Body Works, which sells items people might cut back on when money is tight, this is definitely something to keep an eye on. It hints at potential challenges on the sales front. (Oh, and there was news about an investor in Kenvue, the Band-Aid maker, but that doesn't really tell us anything about BBWI, so we can set that aside).
Putting the news together, it feels like analysts still believe in the company's foundation, but maybe they're getting a bit more cautious about the immediate future or market conditions, leading them to trim their price expectations.
Price Check: Bouncing Off the Bottom?
Looking at the stock's journey over the last couple of months tells a clear story. After trading in the high $30s and even touching $41 back in February, BBWI took a pretty significant tumble through March and into early April. It hit a low point right around $25 in early April – that's its 52-week low, by the way.
Since hitting that low, the stock has bounced back somewhat. It's been trading mostly in the $27 to $30 range recently. The last recorded price point shows it trading just above $30. So, while it's way down from its February highs, it has shown some life after hitting that yearly low.
Now, the AI prediction for the next few days is for small positive moves, like less than 1% each day. This aligns with the idea that the stock might be trying to find its footing or edge up slightly from its recent low point.
Outlook & Ideas: What Might This Mean?
Considering the analyst views (positive ratings, lower targets), the recent price action (big drop, then a bounce from the 52-week low), and the AI's slightly positive short-term prediction, the near-term picture for BBWI seems cautiously optimistic, especially if you're looking at it after the big price drop.
- What's the apparent leaning? It looks like the stock might be in a phase where it's trying to recover from being oversold, or perhaps consolidating after the fall. The combination of analysts still liking the company (ratings) and the price being near its yearly low, despite the lower targets, could suggest it's potentially undervalued in the eyes of some. The negative growth and consumer spending worries are definite risks, though.
- Potential Entry Consideration: The recommendation data pointed to potential entry points around $29.41 to $29.59. The stock is currently trading a bit above that, around $30.62. If you were considering getting in, one approach might be to watch if the stock pulls back towards that $29-$30 area again. That zone acted as resistance recently but could potentially offer support if the bounce continues. Buying closer to the recent lows or the AI's suggested entry zone might be seen as trying to catch the potential upward move from a lower price.
- Potential Exit/Stop-Loss Consideration: If the stock continues to climb, the recommendation data suggested a potential take-profit level around $31.73. This is near some recent highs and could be a point where some traders look to lock in gains. On the flip side, to manage risk if the stock turns south again, a potential stop-loss level suggested is $26.63. Placing a stop-loss below the recent 52-week low ($24.96) or slightly above it, like $26.63, is a common strategy to limit potential losses if the stock breaks down past its recent support area.
Company Context: Retail Sensitivity
Remember, Bath & Body Works is all about selling things like candles and lotions. These are often considered discretionary purchases – things people might cut back on when the economy is shaky or prices are high. So, the news about consumers going discount hunting is particularly relevant here. The company's performance is closely tied to how comfortable people feel spending on non-essentials. On the positive side, its P/E ratio looks quite low compared to the industry average, which is part of why some see it as potentially undervalued despite the challenges.
Disclaimer: This analysis is based on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can go down as well as up. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.
Related News
Wells Fargo Maintains Overweight on Bath & Body Works, Lowers Price Target to $40
Wells Fargo analyst Ike Boruchow maintains Bath & Body Works with a Overweight and lowers the price target from $48 to $40.
Loeb's Third Point builds stake in Band-Aid maker Kenvue
Billionaire investor Daniel Loeb's hedge fund Third Point is building a stake in Kenvue , sources familiar with the matter said on Friday, as some investors are pushing for strategic changes at the consumer healthcare company.
Goldman Sachs Maintains Buy on Bath & Body Works, Lowers Price Target to $42
Goldman Sachs analyst Kate McShane maintains Bath & Body Works with a Buy and lowers the price target from $49 to $42.
Raymond James Maintains Outperform on Bath & Body Works, Lowers Price Target to $37
Raymond James analyst Olivia Tong maintains Bath & Body Works with a Outperform and lowers the price target from $46 to $37.
Consumers Go Discount As Tariff Pressures Mount, Warns Analyst
Retail sector momentum is building as some global brands show improving visibility, while diversified specialty retailers benefit from operational gains and product mix strength.
JP Morgan Maintains Overweight on Bath & Body Works, Lowers Price Target to $41
JP Morgan analyst Matthew Boss maintains Bath & Body Works with a Overweight and lowers the price target from $47 to $41.
AI PredictionBeta
AI Recommendation
Updated at: May 2, 2025, 10:26 PM
56.1% Confidence
Risk & Trading
Entry Point
$30.05
Take Profit
$30.65
Stop Loss
$28.13
Key Factors
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.